Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix Announces Publication on Apabetalone in High-Impact American Journal of Respiratory and Critical Care Medicine (AJRCCM)
Here's some more background about the Resverlogix pulmonary arterial hypertension (PAH) program from a prior post. And here's the prior news release on the trial funding.